Literature DB >> 12921913

Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains.

Shuji Iritani1, Kazuhiro Niizato, Hiroyuki Nawa, Kenji Ikeda, Piers C Emson.   

Abstract

Recently, the pathogenesis of schizophrenia has been investigated from the perspective of neurodevelopmental dysfunction theory. On the other hand, it has been indicated that neurotrophic factors, such as nerve growth factors, brain-derived neurotrophic factor (BDNF), and neurotrophin-3, are significantly involved in the development and functional differences of central nervous system (CNS). Some reports proposed that the dysfunction of these factors could explain the pathogenesis of schizophrenia possibly. In this study, the authors investigated immunohistochemically the distribution and/or morphology of BDNF and TrkB, its peculiar receptor, in the hippocampal formation of schizophrenic brain. As a result, BDNF-positive pyramidal cells in the CA2 and neurons in the CA3 and the field of the CA4 were intensely stained compared to those of normal control. Staining of TrkB-positive neurons showed a signet-ring like shape in the hippocampus of normal control brains. Such figures were not observed on staining of those neurons from schizophrenic brains. In the control cases, TrkB-immunopositive varicose fibers were frequently seen. Those observed differences between schizophrenic and normal cases may indicate the existence of dysfunction of BDNF and TrkB in schizophrenic brain, and this dysfunction may be one of the factors involved in the pathogenesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921913     DOI: 10.1016/S0278-5846(03)00112-X

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  33 in total

Review 1.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan.

Authors:  Shiou-Lan Chen; Sheng-Yu Lee; Yun-Hsuan Chang; Shih-Heng Chen; Chun-Hsieh Chu; Nian-Sheng Tzeng; I-Hui Lee; Po-See Chen; Tzung Lieh Yeh; San-Yuan Huang; Yen-Kuang Yang; Ru-Band Lu; Jau-Shyong Hong
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-23       Impact factor: 4.147

3.  Prenatal stress differentially alters brain-derived neurotrophic factor expression and signaling across rat strains.

Authors:  E W Neeley; R Berger; J I Koenig; S Leonard
Journal:  Neuroscience       Date:  2011-04-07       Impact factor: 3.590

4.  Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder.

Authors:  Benchawanna Soontornniyomkij; Ian P Everall; Gursharan Chana; Ming T Tsuang; Cristian L Achim; Virawudh Soontornniyomkij
Journal:  J Affect Disord       Date:  2011-05-25       Impact factor: 4.839

Review 5.  Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia.

Authors:  Farhana Islam; Benoit H Mulsant; Aristotle N Voineskos; Tarek K Rajji
Journal:  Curr Psychiatry Rep       Date:  2017-07       Impact factor: 5.285

6.  Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.

Authors:  Mia Thompson Ray; Cynthia Shannon Weickert; Eugene Wyatt; Maree J Webster
Journal:  J Psychiatry Neurosci       Date:  2011-05       Impact factor: 6.186

Review 7.  New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases.

Authors:  Naoki Adachi; Tadahiro Numakawa; Misty Richards; Shingo Nakajima; Hiroshi Kunugi
Journal:  World J Biol Chem       Date:  2014-11-26

Review 8.  BDNF-TrkB signaling and neuroprotection in schizophrenia.

Authors:  Chirayu D Pandya; Ammar Kutiyanawalla; Anilkumar Pillai
Journal:  Asian J Psychiatr       Date:  2012-11-03

9.  The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.

Authors:  Shiou-Lan Chen; Sheng-Yu Lee; Yun-Hsuan Chang; Shih-Heng Chen; Chun-Hsien Chu; Tzu-Yun Wang; Po-See Chen; I-Hui Lee; Yen-Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-01-25       Impact factor: 5.067

10.  T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions.

Authors:  Jonathan Kipnis; Hagit Cohen; Michal Cardon; Yaniv Ziv; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.